Template:Oroboros MitoFit box: Difference between revisions
From Bioblast
Laner Verena (talk | contribs) No edit summary |
No edit summary |
||
| Line 8: | Line 8: | ||
* OROBOROS INSTRUMENTS participates in two HORIZON 2020 funded Marie Skłodowska-Curie projects: | * OROBOROS INSTRUMENTS participates in two HORIZON 2020 funded Marie Skłodowska-Curie projects: | ||
:* '''TRACT''' – '''Tra'''ining in '''C'''ancer mechanisms and '''T'''herapeutics: | :* '''TRACT''' – '''Tra'''ining in '''C'''ancer mechanisms and '''T'''herapeutics: PhD network focussed on the three critical areas: biomarker discovery, molecular resistance mechanisms and metabolic transformation mechanisms in oral and oesophageal cancer. '''[[TRACT|More details?]]''' | ||
:*'''TRANSMIT'''- Start in January 2017. '''[http://cordis.europa.eu/project/rcn/205395_en.html More | :*'''TRANSMIT'''- Start in January 2017. '''[http://cordis.europa.eu/project/rcn/205395_en.html More details?]''' | ||
* Horizon 2020 '''COST Action CA15203 MITOEAGLE''' - | * Horizon 2020 '''COST Action CA15203 MITOEAGLE''' - '''[[COST_Action_MITOEAGLE| More details?]]''' | ||
</div> | </div> | ||
Revision as of 00:15, 10 February 2017
- OROBOROS INSTRUMENTS participates in two HORIZON 2020 funded Marie Skłodowska-Curie projects:
- TRACT – Training in Cancer mechanisms and Therapeutics: PhD network focussed on the three critical areas: biomarker discovery, molecular resistance mechanisms and metabolic transformation mechanisms in oral and oesophageal cancer. More details?
- TRANSMIT- Start in January 2017. More details?
- Horizon 2020 COST Action CA15203 MITOEAGLE - More details?
